Learn more

ALLERGAN IND SAS

Overview
  • Total Patents
    173
  • GoodIP Patent Rank
    16,954
  • Filing trend
    ⇩ 36.0%
About

ALLERGAN IND SAS has a total of 173 patent applications. It decreased the IP activity by 36.0%. Its first patent ever was published in 2004. It filed its patents most often in United States, EPO (European Patent Office) and Australia. Its main competitors in its focus markets pharmaceuticals, medical technology and organic fine chemistry are MASTELLI S R L, ALLERGAN INDUSTRIE SAS and VUKICEVIC SLOBODAN.

Patent filings per year

Chart showing ALLERGAN IND SASs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Lebreton Pierre 68
#2 Lebreton Pierre F 42
#3 Gousse Cecile 21
#4 Guetta Olivier 15
#5 Yu Xiaojie 14
#6 Liu Futian 14
#7 Manesis Nicholas J 13
#8 Mandaroux Bastien 12
#9 Ayglon Aurore 12
#10 Roca Martinez Jean-Xavier 11

Latest patents

Publication Filing date Title
US2019224365A1 Implants for sculpting, augmenting or correcting facial features such as the chin
US2018264204A1 Needle array device
US2018206965A1 Thread insertion devices
US2018206964A1 Thread insertion devices
US2018206966A1 Thread insertion devices
US2018206963A1 Thread insertion devices
US2018206967A1 Thread insertion devices
BR112017017346A2 implants to sculpt, augment or correct facial attributes such as the chin
AU2015275313A1 Hyaluronic acid based formulations
AU2015255189A1 A fluid composition comprising a hyaluronan polymer and mannitol for improving skin condition
AU2015252122A1 Hyaluronic acid-based gels including anesthetic agents
AU2015234293A1 Stable hydrogel compositions including additives
WO2016132167A1 Implants for sculpting, augmenting or correcting facial features such as the chin
WO2016128783A1 Compositions and methods for improving skin appearance
EP3620184A1 Stable hydrogel compositions including additives
WO2016005785A1 Hyaluronic acid gels crosslinked by sodium trimetaphosphate
AU2013202365A1 Hyaluronic acid-based gels including anesthetic agents
KR20200000494A Hyaluronic acid formulation containing pyruvate
HUE034824T2 Hyaluronic acid based formulations
US2011171311A1 Stable hydrogel compositions including additives